MTC
CC icon

Matrix Trust Company’s Chemours CC Stock Holding History

Matrix Trust Company’s Portfolio CC Stock Details CC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-5,475
Closed -$65K – 193
2025
Q4 		$65K Sell
5,475
-13,380
-71% -$172K 0.01% 110
2025
Q3 		$299K Sell
18,855
-8,910
-32% -$129K 0.05% 118
2025
Q2 		$318K Buy
27,765
+11,357
+69% +$128K 0.05% 118
2025
Q1 		$222K Buy
16,408
+6,456
+65% +$107K 0.04% 117
2024
Q4 		$168K Buy
9,952
+8,732
+716% +$170K 0.03% 110
2024
Q3 		$25K Buy
+1,220
New +$24.9K ﹤0.01% 110

Other funds holding CC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
WHCM
Wolf Hill Capital Management Greenwich, Connecticut $1.2B AUM 137.35% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Matrix Trust Company's CC Position: Q1 2026 in Review

Matrix Trust Company sold out of Chemours (CC) in Q1 2026, closing a stake of 5,475 shares — an estimated $65K sold.

Matrix Trust Company first reported a position in CC in Q3 2024 and held it in 6 quarters. The position peaked at $318K in Q2 2025. 450 funds tracked by Wall St. Rank hold CC as of Q1 2026.

  • Matrix Trust Company reported no remaining Chemours position as of Q1 2026 after selling out during the quarter.
  • Matrix Trust Company sold 5,475 Chemours shares in Q1 2026, an estimated $65K.
  • Matrix Trust Company first reported a position in Chemours in Q3 2024 and held it in 6 quarters.
  • Matrix Trust Company's Chemours position peaked at $318K in Q2 2025.
  • 450 funds tracked by Wall St. Rank held Chemours as of Q1 2026.

Based on Matrix Trust Company's 13F filing for Q1 2026, filed 10 Apr 2026.